Lucid Diagnostics Inc. (LUCD)
NASDAQ · Healthcare
Lucid Diagnostics Inc. EPS 2021–2025
Lucid Diagnostics Inc. annual/quarterly eps history and growth rate from 2022 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Lucid Diagnostics Inc. eps for the quarter ending September 30, 2025 was $0.10, a 60.00% decrease year-over-year.
- Lucid Diagnostics Inc. annual eps for 2024 was $1.05, a 16.67% decrease from 2023.
- Lucid Diagnostics Inc. annual eps for 2023 was $1.26, a 18.71% decrease from 2022.
- Lucid Diagnostics Inc. annual eps for 2022 was $1.55.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Lucid Diagnostics Inc. EPS — FAQ
Lucid Diagnostics Inc. (LUCD) eps over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LUCD's eps history?
The chart and table above show Lucid Diagnostics Inc.'s eps by year and by quarter, including the growth rate.